Lerodalcibep: What does LIBerate-HeFH tell us?
Professor Derick Raal discusses lerodalcibep data from the LIBerate-HeFH trial and explains what the results mean to practising clinicians.
Related content:
LIBerate-HeFH: Lerodalcibep reduces LDL-C in HeFH